Abstract
SummaryA study was carried out to determine the rate of elimination of flurbiprofen in 9 rheumatoid patients who had been receiving high doses (200 mg. or more daily)of the drug for almost a year. The data were compared with those previously obtained from 19 healthy volunteers after single doses (50 mg.)and limited repeated dosage (3 × 50 mg. daily for 9 days). The results showed no apparent change in the pharmacokinetics of flurbiprofen in patients on long-term therapy and serum concentrations were similar to those calculated in the volunteers. It is concluded that frurbiprofen neither induces nor inhibits its own metabolism when given over long periods to human subjects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
